HARP - Harpoon Therapeutics GAAP EPS of -$0.66 misses by $0.23 revenue of $4.3M misses by $1.9M March, 10 2022 06:12 PM Harpoon Therapeutics Inc. Harpoon Therapeutics press release (NASDAQ:HARP): Q4 GAAP EPS of -$0.66 misses by $0.23. Revenue of $4.3M (-42.7% Y/Y) misses by $1.9M. For further details see: Harpoon Therapeutics GAAP EPS of -$0.66 misses by $0.23, revenue of $4.3M misses by $1.9M